PortfoliosLab logoPortfoliosLab logo
CI vs. MELI
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

CI vs. MELI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Cigna Corporation (CI) and MercadoLibre, Inc. (MELI). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

CI vs. MELI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CI
Cigna Corporation
-2.55%1.72%-6.27%-7.97%46.68%12.29%1.83%7.70%-6.46%52.29%
MELI
MercadoLibre, Inc.
-14.16%18.46%8.20%85.71%-37.24%-19.51%192.90%95.30%-6.93%101.99%

Fundamentals

Market Cap

CI:

$70.94B

MELI:

$87.66B

EPS

CI:

$22.28

MELI:

$39.39

PE Ratio

CI:

11.97

MELI:

43.89

PEG Ratio

CI:

0.69

MELI:

0.26

PS Ratio

CI:

0.26

MELI:

3.03

PB Ratio

CI:

1.70

MELI:

12.99

Total Revenue (TTM)

CI:

$274.95B

MELI:

$28.89B

Gross Profit (TTM)

CI:

$25.99B

MELI:

$12.86B

EBITDA (TTM)

CI:

$12.17B

MELI:

$4.02B

Returns By Period

In the year-to-date period, CI achieves a -2.55% return, which is significantly higher than MELI's -14.16% return. Over the past 10 years, CI has underperformed MELI with an annualized return of 7.90%, while MELI has yielded a comparatively higher 30.58% annualized return.


CI

1D
3.36%
1M
-7.45%
YTD
-2.55%
6M
-6.43%
1Y
-17.21%
3Y*
3.35%
5Y*
3.84%
10Y*
7.90%

MELI

1D
6.78%
1M
-1.62%
YTD
-14.16%
6M
-26.01%
1Y
-11.37%
3Y*
9.47%
5Y*
2.74%
10Y*
30.58%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CI vs. MELI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CI
CI Risk / Return Rank: 2020
Overall Rank
CI Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
CI Sortino Ratio Rank: 2020
Sortino Ratio Rank
CI Omega Ratio Rank: 1818
Omega Ratio Rank
CI Calmar Ratio Rank: 2323
Calmar Ratio Rank
CI Martin Ratio Rank: 2121
Martin Ratio Rank

MELI
MELI Risk / Return Rank: 2828
Overall Rank
MELI Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
MELI Sortino Ratio Rank: 2727
Sortino Ratio Rank
MELI Omega Ratio Rank: 2727
Omega Ratio Rank
MELI Calmar Ratio Rank: 3030
Calmar Ratio Rank
MELI Martin Ratio Rank: 2727
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CI vs. MELI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Cigna Corporation (CI) and MercadoLibre, Inc. (MELI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CIMELIDifference

Sharpe ratio

Return per unit of total volatility

-0.52

-0.29

-0.23

Sortino ratio

Return per unit of downside risk

-0.49

-0.16

-0.33

Omega ratio

Gain probability vs. loss probability

0.92

0.98

-0.06

Calmar ratio

Return relative to maximum drawdown

-0.59

-0.40

-0.19

Martin ratio

Return relative to average drawdown

-1.14

-0.89

-0.25

CI vs. MELI - Sharpe Ratio Comparison

The current CI Sharpe Ratio is -0.52, which is lower than the MELI Sharpe Ratio of -0.29. The chart below compares the historical Sharpe Ratios of CI and MELI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


CIMELIDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.52

-0.29

-0.23

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

0.06

+0.08

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.26

0.63

-0.37

Sharpe Ratio (All Time)

Calculated using the full available price history

0.34

0.46

-0.12

Correlation

The correlation between CI and MELI is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

CI vs. MELI - Dividend Comparison

CI's dividend yield for the trailing twelve months is around 2.28%, while MELI has not paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
CI
Cigna Corporation
2.28%2.19%2.03%1.64%1.35%1.74%0.02%0.02%0.02%0.02%0.03%0.03%
MELI
MercadoLibre, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.19%0.38%0.36%

Drawdowns

CI vs. MELI - Drawdown Comparison

The maximum CI drawdown since its inception was -84.34%, smaller than the maximum MELI drawdown of -89.49%. Use the drawdown chart below to compare losses from any high point for CI and MELI.


Loading graphics...

Drawdown Indicators


CIMELIDifference

Max Drawdown

Largest peak-to-trough decline

-84.34%

-89.49%

+5.15%

Max Drawdown (1Y)

Largest decline over 1 year

-27.41%

-38.80%

+11.39%

Max Drawdown (5Y)

Largest decline over 5 years

-32.10%

-68.64%

+36.54%

Max Drawdown (10Y)

Largest decline over 10 years

-42.47%

-69.12%

+26.65%

Current Drawdown

Current decline from peak

-25.07%

-33.85%

+8.78%

Average Drawdown

Average peak-to-trough decline

-18.81%

-23.47%

+4.66%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.19%

17.45%

-3.26%

Volatility

CI vs. MELI - Volatility Comparison

The current volatility for Cigna Corporation (CI) is 8.29%, while MercadoLibre, Inc. (MELI) has a volatility of 12.28%. This indicates that CI experiences smaller price fluctuations and is considered to be less risky than MELI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


CIMELIDifference

Volatility (1M)

Calculated over the trailing 1-month period

8.29%

12.28%

-3.99%

Volatility (6M)

Calculated over the trailing 6-month period

27.62%

31.85%

-4.23%

Volatility (1Y)

Calculated over the trailing 1-year period

33.11%

39.25%

-6.14%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

28.13%

49.49%

-21.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.71%

48.62%

-17.91%

Financials

CI vs. MELI - Financials Comparison

This section allows you to compare key financial metrics between Cigna Corporation and MercadoLibre, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
72.47B
8.76B
(CI) Total Revenue
(MELI) Total Revenue
Values in USD except per share items

CI vs. MELI - Profitability Comparison

The chart below illustrates the profitability comparison between Cigna Corporation and MercadoLibre, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
7.7%
43.2%
Portfolio components
CI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Cigna Corporation reported a gross profit of 5.55B and revenue of 72.47B. Therefore, the gross margin over that period was 7.7%.

MELI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, MercadoLibre, Inc. reported a gross profit of 3.78B and revenue of 8.76B. Therefore, the gross margin over that period was 43.2%.

CI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Cigna Corporation reported an operating income of 2.15B and revenue of 72.47B, resulting in an operating margin of 3.0%.

MELI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, MercadoLibre, Inc. reported an operating income of 889.00M and revenue of 8.76B, resulting in an operating margin of 10.2%.

CI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Cigna Corporation reported a net income of 1.23B and revenue of 72.47B, resulting in a net margin of 1.7%.

MELI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, MercadoLibre, Inc. reported a net income of 559.00M and revenue of 8.76B, resulting in a net margin of 6.4%.